SELLAS Life Sciences Group, Inc. (SLS) Social Stream



SELLAS Life Sciences Group, Inc. (SLS): $5.07

-0.23 (-4.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SLS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

SELLAS Life Sciences Group Inc (SLS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering SELLAS Life Sciences Group Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-03 1 $21 $16 $18.5 $5.3 249.06%
2021-08-13 2 $21 $18 $19.5 $5.3 267.92%
2021-12-03 2 $21 $16 $18.5 $5.3 249.06%

Price Target Last Issued December 3, 2021

The Trend in the Analyst Price Target


SLS's average price target has moved up $8.5 over the prior 45 weeks.

Over the past 45 weeks, SLS's average upside potential has been 63.65%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 0 12 8 10.0 9.11 9.77%
2021-12-03 2 21 16 18.5 6.14 201.3%
2021-05-08 0 12 8 10.0 8.07 23.92%
2021-05-15 0 12 8 10.0 8.15 22.7%
2021-02-27 2 12 8 10.0 8.13 23%

SLS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 122 days, SLS's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SLS as an investment opportunity.

  • In the context of all US stocks, SELLAS Life Sciences Group Inc's number of analysts covering the stock is higher than 11.12% of them.
  • SLS has a higher upside potential (average analyst target price relative to current price) than 273.72% of all US stocks.
  • SLS has a lower variance in analysts' estimates than 35.5% of Pharmaceutical Products stocks.
  • SELLAS Life Sciences Group Inc's average analyst price target is higher than 94.74% of Healthcare stocks.

Stocks similar to SELLAS Life Sciences Group Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SLRX, SLGL, and SIGA.

Is SLS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6712 seconds.